The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScirocco Energy Regulatory News (SCIR)

Share Price Information for Scirocco Energy (SCIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.315
Bid: 0.28
Ask: 0.35
Change: 0.015 (5.00%)
Spread: 0.07 (25.00%)
Open: 0.30
High: 0.325
Low: 0.30
Prev. Close: 0.30
SCIR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Broker and Director/PDMR Shareholdings

31 Dec 2020 07:00

RNS Number : 2053K
Scirocco Energy PLC
31 December 2020
 

31 December 2020

 

Scirocco Energy plc

("Scirocco" of "the Company") 

Appointment of Corporate Broker and Director / PDMR Shareholdings

Scirocco Energy (AIM: SCIR), the AIM investing company targeting attractive production and development opportunities within the European energy market, makes the following announcement in respect of the appointment of a sole corporate broker and of a disclosable transaction carried out by one of its Directors on 30 December 2020.

Appointment of a sole Corporate Broker

Scirocco is pleased to announce the appointment of WH Ireland Limited ("WH Ireland") as Corporate Broker to the Company, effective immediately.

Directors Salaries and Operating Costs update

To continue to preserve cash within the Company, the Board has agreed to extend the Director Options plan, announced on 2 July 2020, granting nominal cost options to Non-Executive Chairman Alastair Ferguson and Non-Executive Director Jon Fitzpatrick through to 31 December 2021. To date, no Board member has been paid in cash since March 2020.

The extension of the Directors Option plan to year-end 2021 will save the Company £144,000 in cash by part settling the 2021 Non-Executive Directors fees through the issue of nominal cost options. The decision further aligns the Board with the performance of the Company and is a core component of the Board's highly disciplined focus on costs.

The Board has worked hard to ensure that the business has reduced its cost base in line with its current level of activity and is estimating a baseline FY2021 corporate overhead of c.£500,000 (excluding exceptional expenses and contingencies). The Company's ongoing requirements will be reviewed on or around 30 June 2021 to ensure that the business continues to have access to the appropriate ongoing financial, technical, commercial and operational support to meet its future activities and stated objectives.

As at today's date, the Company has in excess of US$3.6 million in cash and near-term equivalents. Additionally, the Company has access to a committed US$1 million tranche (and up to a further undrawn US$3 million under certain conditions) under the Cash Facility Agreement that the Company entered into with Prolific Basins LLC in June 2020.

Grant of Option to Mr Alastair Ferguson

The Company has granted a nominal cost option over 2,783,295 new ordinary shares of 0.2p each in the Company ("Shares") to Mr Alastair Ferguson, who is a director of the Company (the "Option"). The Option has been granted to Mr Ferguson in lieu of the directors' fees due to him over the period from 1 July 2020 to 31 December 2021.

For the calendar year 2020, Mr Ferguson has been paid £9,000 in cash for his work as Non-Executive Chairman with all other fees and salaries to be commuted into Shares under the Option. Further Shares shall accrue under the Option on a month-by-month basis by reference to Directors' fees due to Mr Ferguson for the relevant month over the remainder of the period to 31 December 2021.

Other than the period over which Mr Ferguson's Directors' fees may be accrued as Shares, the terms of the Option are materially similar to the terms of the options granted by the Company to each of its directors and members of the Executive Management team (excluding Mr Ferguson) on 29 June 2020 (and announced by the Company on 2 July 2020).

An appropriate Notification of Dealing Form in respect of the Option can be found below.

For further information:

Scirocco Energy plc

Tom Reynolds, CEO

Doug Rycroft, COO

+44 (0) 20 7466 5000

 

Strand Hanson Limited, Nominated Adviser

James Spinney / Ritchie Balmer / Rory Murphy

 

+44 (0) 20 7409 3494

 

 

WH Ireland Limited, Broker

Harry Ansell / Katy Mitchell

 

+44 (0) 0207 220 1666

 

 

Buchanan, Financial PR

Ben Romney / Kelsey Traynor / James Husband

 

 

+44 (0) 20 7466 5000

 

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933 (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States. The securities may not be offered or sold in the United States, except pursuant to an applicable exemption from or in a transaction not subject to the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the securities is being made in the United States. 

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

 

 

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Alastair Ferguson

 

2.

Reason for the notification

a)

Position/status

Chairman / PDMR

 

b)

Initial notification/ Amendment

 

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Scirocco Energy PLC

 

b)

LEI

213800Z1HYXMO2FSDM70

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Ordinary shares of £0.002 each

 

 

 

Identification code

ISIN: GB00BF1BK408

b)

Nature of the transaction

Grant of a nominal cost option over ordinary shares of £0.002 each in lieu of director's fees due to the PDMR for the period from 1 July 2020 to 31 December 2021

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

Not less than 2,783,295

d)

Aggregated information

 

Aggregated volume

Price

 

Not applicable - single transaction

e)

Date of the transaction

30 December 2020

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCURRURROUUOUA
Date   Source Headline
27th Sep 20213:04 pmRNSNotification of Major Holdings
24th Sep 20217:00 amRNSAward of Seismic Acquisition Contract
13th Sep 20218:57 amRNSNotice of Investor Webinar
26th Aug 202110:07 amRNSHelium One Update
25th Aug 20217:00 amRNSCompletion of Investment
19th Aug 202110:12 amRNSHelium One Update
18th Aug 202110:00 amRNSExtension of Ruvuma Licence
11th Aug 20211:06 pmRNSHelium One Update
27th Jul 20213:01 pmRNSHelium One Limited – Investment Update
12th Jul 202111:01 amRNSHelium One Update
9th Jul 20212:39 pmRNSResult of Annual General Meeting
5th Jul 20214:36 pmRNSResponse to Investor Forum Speculation
1st Jul 20217:00 amRNSTanzania Operations Update
25th Jun 20217:00 amRNSAmendment of Investment Facility
21st Jun 202112:01 pmRNSHelium One Update
21st Jun 20217:00 amRNSShareholder Q&A Audiocast
14th Jun 202111:10 amRNSHelium One Update
14th Jun 20217:01 amRNSFull-Year Results 2020 and Notice of AGM
14th Jun 20217:00 amRNSProposed Investment into EAG and Biogas Market
18th May 20217:00 amRNSHelium One Global – Investment Update
13th May 20219:35 amRNSHelium One Update
11th May 20212:06 pmRNSSecond Price Monitoring Extn
11th May 20212:00 pmRNSPrice Monitoring Extension
5th May 20211:03 pmRNSInvestment Facility Part Settlement and TVR
4th May 20219:08 amRNSHelium One Update
30th Apr 202111:05 amRNSSecond Price Monitoring Extn
30th Apr 202111:00 amRNSPrice Monitoring Extension
29th Apr 20212:05 pmRNSSecond Price Monitoring Extn
29th Apr 20212:00 pmRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSWH Ireland Initiates Coverage on Scirocco
26th Mar 202111:00 amRNSPrice Monitoring Extension
22nd Mar 20217:15 amRNSHelium One Update
16th Mar 20219:12 amRNSHelium One Update
15th Mar 20217:00 amRNSDisposal of Ausable Reef assets
24th Feb 20217:00 amRNSAudiocast of Corporate Presentation
19th Feb 20212:06 pmRNSSecond Price Monitoring Extn
19th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20211:55 pmRNSNew Corporate Presentation
18th Feb 202111:06 amRNSSecond Price Monitoring Extn
18th Feb 202111:00 amRNSPrice Monitoring Extension
18th Feb 20217:15 amRNSHelium One Update
18th Feb 20217:00 amRNSStrategy Update and Board Changes
20th Jan 20212:30 pmRNSHelium One Update
12th Jan 20213:51 pmRNSHelium One Update
31st Dec 20207:00 amRNSNew Broker and Director/PDMR Shareholdings
4th Dec 20201:53 pmRNSHelium One Update
23rd Nov 20207:00 amRNSRuvuma PSA Update
16th Nov 20205:38 pmRNSNotification of Major Holdings
16th Nov 202010:08 amRNSHelium One Update
5th Nov 20207:11 amRNSHelium One Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.